PsychotherapyNCT05151354
Attachment, Patient Self-disclosure and Psychotherapy Outcome
An observational study of Psychotherapy and Attachment, run by University Hospital Heidelberg.
Trial summary
This study investigates whether within- and between-patient effects of attachment moderate the association between self-disclosure and psychotherapy outcome. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Psychotherapy, Attachment, Self Disclosure
- What is being tested?
- Psychotherapy
- How many people
- 1,500 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2015to 1 Sep 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population consists of patients undergoing inpatient treatment at the university hospital Heidelberg.
Who may be able to join
- patients of at least 18 years of age
- treated at the inpatient unit of a hospital for psychosomatic medicine
- provided measurements of symptoms, attachment style, and self-disclosure for at least one measurement occasion
Who cannot join
- bipolar, acute psychotic or substance abuse disorders
About this study
Official title: Attachment as a Moderator of the Relationship Between Patient Self-disclosure and Psychotherapy Outcome: Separating Within- From Between-patient Effects
This study investigates whether within- and between-patient effects of attachment moderate the association between self-disclosure and psychotherapy outcome.
Read the detailed description
Participants are recruited at the University Clinic Heidelberg at the beginning of their (usually) 8-week inpatient treatment. After informed consent, patients routinely fill out weekly questionnaires on attachment, self-disclosure, and symptom severity.
This study is the first to disentangle stable, trait-like (between-person) effects of both attachment and self-disclosure from within-person changes over the course of treatment. The study investigates whether (changes in) attachment moderate the association between (changes in) self-disclosure and psychotherapy outcome.
- Conditions
- Psychotherapy, Attachment, Self Disclosure, Treatment Outcome
- Being tested
- Psychotherapy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PsychotherapyOther
Patients receive 8 weeks of inpatient psychotherapeutic treatment. Treatment consists of individual and group psychodynamic psychotherapy, as well as an individual combination of art, music, body-oriented and relaxation therapies, which are also carried out in group settings. Treatments is provided by an interdisciplinary team of psychotherapists with a medical or psychology degree, art of music therapists, social workers, physiotherapists and specialist nurses.
What is being measured
The primary outcome is the main question the study is designed to answer.
Symptom Checklist Short Form (SCL-K11)
Symptom measure
Measured: for each participant: weekly assessment for 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continous study enrollment (2014 - 2021)
Secondary outcomes (2)
Relationship Questionnaire 2 (RQ-2)
Attachment measure
Measured: for each participant: weekly assessment for 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continous study enrollment (2014 - 2021)
Inpatient and day clinic experiences questionnaire (IDES)
measure of self-disclosure and other treatment factors
Measured: for each participant: weekly assessment for 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continous study enrollment (2014 - 2021)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Dec 2021
- Study start1 Jan 2015
- Primary completion1 Sep 2021
- Study completion1 Sep 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PsychotherapyStudies of the same condition, open and under way.
- More trials run by University Hospital HeidelbergThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,500 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital Heidelberg
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Simone Jennissen, University Hospital Heidelberg
- Investigators
- Ulrike Dinger, Prof, Study chair, University Hospital Heidelberg
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05151354
- Sponsor's protocol ID
- Attach-Sel-2021
- Status last verified
- Nov 2021
- First submitted
- 15 Nov 2021
- Last updated
- 9 Dec 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Dec 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Attachment as a Moderator of the Relationship Between Patient Self-disclosure and Psychotherapy Outcome: Separating Within- From Between-patient Effects
- ClinicalTrials.gov ID
- NCT05151354
- Acronym / sponsor ID
- Attach-Sel-2021
- Conditions
- Psychotherapy, Attachment, Self Disclosure, Treatment Outcome
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,500 participants (actual)
- Lead sponsor
- University Hospital HeidelbergUniversity, hospital or other
- Study start
- 1 Jan 2015 (actual)
- Primary completion
- 1 Sep 2021 (actual)
- Study completion
- 1 Sep 2021 (actual)
- First posted
- 9 Dec 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study investigates whether within- and between-patient effects of attachment moderate the association between self-disclosure and psychotherapy outcome.
Detailed description
Participants are recruited at the University Clinic Heidelberg at the beginning of their (usually) 8-week inpatient treatment. After informed consent, patients routinely fill out weekly questionnaires on attachment, self-disclosure, and symptom severity.
This study is the first to disentangle stable, trait-like (between-person) effects of both attachment and self-disclosure from within-person changes over the course of treatment. The study investigates whether (changes in) attachment moderate the association between (changes in) self-disclosure and psychotherapy outcome.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population consists of patients undergoing inpatient treatment at the university hospital Heidelberg.
Key inclusion criteria (3 listed)
- patients of at least 18 years of age
- treated at the inpatient unit of a hospital for psychosomatic medicine
- provided measurements of symptoms, attachment style, and self-disclosure for at least one measurement occasion
Key exclusion criteria (1 listed)
- bipolar, acute psychotic or substance abuse disorders
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PsychotherapyPatients receive 8 weeks of inpatient psychotherapeutic treatment. Treatment consists of individual and group psychodynamic psychotherapy, as well as an individual combination of art, music, body-oriented and relaxation therapies, which are also carried out in group settings. Treatments is provided by an interdisciplinary team of psychotherapists with a medical or psychology degree, art of music therapists, social workers, physiotherapists and specialist nurses. | Other | – |
Primary outcome
Symptom Checklist Short Form (SCL-K11)
Time frame: for each participant: weekly assessment for 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continous study enrollment (2014 - 2021)
Symptom measure
2 secondary outcomes
Relationship Questionnaire 2 (RQ-2)
Time frame: for each participant: weekly assessment for 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continous study enrollment (2014 - 2021)
Inpatient and day clinic experiences questionnaire (IDES)
Time frame: for each participant: weekly assessment for 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continous study enrollment (2014 - 2021)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Dec 2021.
- Individual participant dataSharing planned: No
Related trials for Psychotherapy
RecruitingPhase 2
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
Depression, Anxiety, Psilocybin-Assisted Psychotherapy
Active, not recruitingPhase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Grief, Trauma
Recruiting
Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine
Psychotherapy, Integrative Medicine
Recruiting
Digital Mental Health for Asian Americans
Mental Health, Cultural Adaptation
Recruiting
SMART Therapist Training: A Hybrid Factorial-SMART Design
Stress Disorders, Post-Traumatic, Psychotherapy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ulrike Dinger, Prof study chair
University Hospital Heidelberg
Questions about this trial
What is this clinical trial studying?
An observational study of Psychotherapy and Attachment, run by University Hospital Heidelberg.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Symptom Checklist Short Form (SCL-K11) (time frame: for each participant: weekly assessment for 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continous study enrollment (2014 - 2021)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2021.